Hikma given US regulatory clearance for Eatontown facility
2nd Apr 2014 07:57
Jordanian drug group Hikma Pharmaceuticals has been told by the US regulator that its Eatontown oral products facility in New Jersey has passed inspection. Hikma has spent $45m in remediation on Eatontown after receiving a warning letter from the US Food and Drug Administration (FDA). A letter fro
Read moreFTSE 250 movers: Crest Nicholson hit by reports of major shareholder sale
21st Mar 2014 14:00
Crest Nicholson dropped after Bloomberg reported that the housebuilder's largest publicly disclosed shareholder, Deutsche Bank, is disposing of as many as 16.5m shares. The German bank is thought to have a 10 per cent stake in the company. Pharmaceuticals firm Hikma was also trading in the red toda
Read moreJefferies downgrades Hikma on limited upside
21st Mar 2014 12:14
Jefferies has lowered its recommendation for Hikma Pharmaceuticals from 'buy' to 'hold' and slashed its target price from 1,500p to 1,250p, saying that upside for the stock is now limited after its recent strong run. "We continue to view Hikma as a quality business but re-evaluate the stock after a
Read moreLondon midday: Stocks set for weekly gain as miners rise
21st Mar 2014 11:45
- Miners recover after recent slump - Obama imposes more sanctions on Russia - Markets await speeches from Fed officials - Burberry, RBS, Hikma hit by broker downgrades techMARK 2,807.91 +0.27% FTSE 100 6,564.71 +0.34% FTSE 250 16,228.56 +0.07% UK equities were trading higher on Friday with the FT
Read moreFriday broker round-up UPDATE
21st Mar 2014 09:36
Anglo American: Nomura reduces target price from 1550p to 1475p and retains a neutral rating. Antofagasta: Nomura cuts target price from 800p to 720p and stays with its reduce rating. Canaccord Genuity reduces target price from 1030p to 880p, while its buy recommendation is kept. ASOS: UBS reduces
Read moreLondon open: Mining stocks provide a lift early on
21st Mar 2014 08:27
- Miners recover after recent slump - Obama imposes more sanctions on Russia - Markets await speeches from Fed officials techMARK 2,803.23 +0.11% FTSE 100 6,565.89 +0.36% FTSE 250 16,219.13 +0.01% UK equities opened slightly higher on Friday as decent gains in the mining sector lifted the resource
Read moreTuesday broker round-up UPDATE
18th Mar 2014 08:58
Antofagasta: Investec places its target price (prev.: 753p) under review, while leaving its sell recommendation unchanged. Ashtead Group: Credit Suisse raises target price from 1000p to 1100p and stays with its outperform rating. UBS increases target price from 875p to 1020p retaining its buy recom
Read moreMonday broker round-up UPDATE
17th Mar 2014 08:31
Admiral Group: Credit Suisse raises target price from 1340p to 1425p and keeps a neutral rating. African Barrick Gold: Canaccord Genuity ups target price from 315p to 330p and maintains a buy recommendation. Amara Mining: Canaccord Genuity moves target price from 25p to 33p and reiterates its buy
Read moreThursday tips round-up: Ocado, Hikma Pharmaceuticals
13th Mar 2014 10:09
Ocado's share price is riding on a lot of assumptions. So much so that in a rational market its shares should not be where they are and they should not be headed any higher. At the moment it is trading at a price-to-earnings multiple of 200 and even if it meets forecasts that would still leave share
Read moreFTSE 250 movers: Hikma Pharmaceuticals jumps after strong 2013
12th Mar 2014 14:43
Powerful revenue growth from its generic drugs and solid growth elsewhere helped Hikma Pharmaceutical post impressive results for 2013. Group revenue increased 23% to $1,365m and a 30% strengthening of operating margins from improvements in the Generics and Injectables businesses helped group prof
Read moreWednesday broker round-up UPDATE
12th Mar 2014 09:03
Ashtead Group: Citi raises target price from 850p to 1075p keeping a buy recommendation. Barratt Developments: Goldman Sachs reduces target price from 527p to 502p and downgrades to neutral. British Land: Jefferies downgrades to hold with a target price of 707p. Brooks Macdonald Group: Canaccord
Read moreLondon pre-open: Potential second Chinese bond default to hit FTSE
12th Mar 2014 07:45
- FTSE to open around 60 points lower - Reports of potential second bond default in China - Data out on US Crude Oil Inventories and EU Industrial Production The City is set to start the day firmly in reverse on the back of reports of another bond default in China and a negative finish in the US la
Read moreHikma Pharma ups dividend as generics generate generous cash - UPDATE
12th Mar 2014 07:07
- Revenue and EPS up 23 and 111 per cent - Final and special dividend of 13c and 4c - Growth expected in 2014 despite pullback in generics Powerful revenue growth from its generic drugs and solid growth elsewhere helped Hikma Pharmaceutical post impressive results for 2013. Group revenue increas
Read moreTuesday broker round-up UPDATE
11th Mar 2014 09:03
Aviva: RBC Capital takes target price from 400p to 550p upgrading to neutral. Nomura increases target price from 489p to 625p and reiterates a buy recommendation. Balfour Beatty: Citi raises target price from 220p to 310p maintaining a neutral rating. Goldman Sachs reduces target price from 335p to
Read moreFTSE 250 movers: Kazakhmys extends rise on currency valuation change
14th Feb 2014 14:48
Copper miner Kazakhmys surged today, extending gains made earlier this week after the Kazakh government devalued its local currency which investors hope will lead to lower costs for the firm. Shares of Essar Energy are rocketing after the company announced that all main units have resumed operation
Read more